Bruker Corporation

NASDAQ:BRKR

44.97 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 3,366.42,964.52,530.72,417.91,987.52,072.61,895.61,765.91,611.31,623.81,808.91,839.41,791.41,651.71,304.91,114.51,107.1547.576435.834297.569284.416260.679116.36892.69176.60264.6942.207
Cost of Revenue 1,716.91,451.21,2251,208.31,047.71,077.3995.6952.9868.8915.21,045.61,034.2960899.2698.9595.9602.1294.438236.5171.762165.94144.83455.87243.58835.58728.1310
Gross Profit 1,649.51,513.31,305.71,209.6939.8995.3900813742.5708.6763.3805.2831.4752.5606518.6505253.138199.334125.807118.476115.84560.49649.10341.01536.55942.207
Gross Profit Ratio 0.490.510.5160.50.4730.480.4750.460.4610.4360.4220.4380.4640.4560.4640.4650.4560.4620.4570.4230.4170.4440.520.530.5350.5651
Reseach & Development Expenses 376.5294.8235.9220.8198187.7173.4162.7149145.7174.2190.5195.3177.2141.4126.4133.858.46649.95941.35743.21938.02620.73418.46820.03315.1380
General & Administrative Expenses 893.8730.1610.8564.5477.8500.2444.7415.9390.5392.2451437.9442.4406.6303.169.5254.5140.041112.98973.81276.37577.75533.81527.71820.24814.7560
Selling & Marketing Expenses 00-3.4-3.3-9.200000000-3-5.8185.8183.8105.98384.00751.43855.97660.4226.80621.711000
SG&A 893.8730.1607.4561.2468.6500.2444.7415.9390.5392.2451437.9442.4403.6297.3255.3254.5140.041112.98973.81276.37577.75533.81527.71820.24814.7560
Other Expenses 126.152.2-29.7-14.3-24.9-6.5-19.5-19.7-25.8-20.4-21.2-28.6-13.913.15.80.28.54.6645.724009.7450.202-0.35603.48742.368
Operating Expenses 1,396.41,082.4843.3782666.6687.9618.1578.6539.5537.9625.2628.4637.7596.9450.3255.3388.3198.507162.948115.169119.594125.52654.75145.8340.28133.38142.368
Operating Income 253.1436.9432.7413.3248.3300.9262.4214.7177.2145.7105.4148.2156155.6155.7136.7108.249.96730.66210.638-1.118-9.6815.7453.2730.7343.178-0.161
Operating Income Ratio 0.0750.1470.1710.1710.1250.1450.1380.1220.110.090.0580.0810.0870.0940.1190.1230.0980.0910.070.036-0.004-0.0370.0490.0350.010.049-0.004
Total Other Income Expenses Net -48.6107.3-18.8-19.7-22.5-20.5-17.7-21.7-4.2-17.7-4.1-23.6-17.7-10.1-5.6-7.6-15-89.0883.758-0.78-3.7791.851-9.8822.7331.586-1.3150.161
Income Before Tax 204.5544.2413.9393.6225.8280.4244.7197.8177.6128101.3124.6138.3145.5150.1129.193.248.61234.4211.949-4.897-7.83-4.1376.0062.321.8630
Income Before Tax Ratio 0.0610.1840.1640.1630.1140.1350.1290.1120.110.0790.0560.0680.0770.0880.1150.1160.0840.0890.0790.04-0.017-0.03-0.0360.0650.030.0290
Income Tax Expense 91.4117.7116.411364.482.463.7117.523.123.141.742.860.151.553.348.12816.78415.9318.2632.8659.7242.0632.3690.2540.9870
Net Income 113.1427.2296.6277.1157.8197.2179.778.6153.6101.656.780.177.592.395.481.264.931.52918.4813.646-7.831-17.554-6.23.6372.251.250
Net Income Ratio 0.0340.1440.1170.1150.0790.0950.0950.0450.0950.0630.0310.0440.0430.0560.0730.0730.0590.0580.0420.012-0.028-0.067-0.0530.0390.0290.0190
EPS 0.762.9221.831.031.271.150.50.950.60.340.480.470.560.580.50.40.610.180.1-0.081-0.17-0.12-0.050.040.030
EPS Diluted 0.762.91.991.811.021.261.140.490.950.60.330.480.460.550.580.490.390.60.180.096-0.081-0.17-0.12-0.050.040.030
EBITDA 253.1599545.3497.1320.7380340.1299.5262.1235.9215.6239.1211.7205.7155.7166.3134.863.07449.86819.2468.6750.69717.4710.2954.8796.665-0.161
EBITDA Ratio 0.0750.2020.2170.2140.1780.1850.1830.1690.160.1410.1160.1290.1210.0960.1240.3570.1480.1330.1190.0650.0310.0590.2080.0970.0660.109-0.004